JPRN-UMIN000024088尚未招募1 期
Phase I trial of Nabpaclitaxel combinated radiotherapy for adenocarcinoma of the esophago-gastric junction - Phase I trial of Nabpaclitaxel combinated radiotherapy for adenocarcinoma of the esophago-gastric junction
Tokyo Women's Medical University0 个研究点目标入组 24 人开始时间: 2016年9月17日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Nobody performe nabpaclitaxcel before 2)Nobody use blood protacts within 2weeks3)Without drug hypersensitivity 4)Neuropathy level is more than Grade2 5)the patients who have another cancer in the time of entry. 6)With severe complication 7)With infection or chronic inflametory disease 8)Patient use the steroid 9)The patient is pregnancy 10)Male whose partner is pregnancy is possibility from now. 11)It is difficult to decide to take part in this trial with Mentaldisease 12)Docters decides patients are unsuitable for this study.
研究者
相似试验
已完成
1 期
Phase I trial of weekly nab-paclitaxel plus cyclophosphamide for metastatic breast canceradvanced or metastatic breast cancerJPRN-UMIN000010945Mitsui Memorial Hospital Department of Breast Endocrine Surgery9
已完成
1 期
Phase I/II trial of nab-Paclitaxel,Carboplatin,plus Bevacizumab chemotherapy for patients with advanced Non-Squamous Non-Small Cell Lung Cancer.Advanced Non-Squamous Non-Small Cell Lung CancerJPRN-UMIN000013201Cancer Institute Hospital of JFCR61
尚未招募
1 期
A phase I trial of biweekly nab-paclitaxel plus ramucirumab in patients with previously treated advanced gastric cancermetastatic or recurrent gastric cancerJPRN-UMIN000021949Tokushima University Hospital10
已完成
1 期
Phase 1 trial of Nab-paclitaxel and Gemcitabine for metastatic breast cancerBreast cancerJPRN-UMIN000010125Tokyo-West Tokushukai Hospital6
进行中（未招募）
1 期
Phase II trial of nab-paclitaxel for the treatment of desmoid tumors and multiply relapsed/refractory desmoplastic small round cell tumors and Ewing sarcomaEUCTR2016-002464-14-ESGrupo Español de Investigación en Sarcomas (GEIS)61